Henry Schein has reached an agreement for the acquisition of Brazilian company S.I.N. Implant System from the Southern Cross Group for an undisclosed sum.
S.I.N. is engaged in the manufacturing of a wide range of products to carry out dental implant procedures.
The company, established in 2003, is primarily focused on advancing value-priced dental implant development.
Recently, the company has extended the supply of its products to the US and other major global markets.
The deal will allow Henry Schein, which has been providing services to dental practitioners in Brazil since 2014, to enter the country’s dental implant market.
S.I.N. president Felipe Leonard said: “By joining forces with Henry Schein, a world leader in dental products and related services, we will accelerate our growth in Brazil as well as advance our global expansion.”
Subject to approval by Brazil’s Administrative Council for Economic Defense, the deal is expected to be completed in the second half of this year.
After the completion of the deal, S.I.N. will be included in Henry Schein’s Global Oral Reconstruction Group.
The group also comprises BioHorizons, Camlog, Biotech Dental and Medentis Medical, which offer dental implant systems and restorative components along with a comprehensive range of biologics products and digital solutions.
Henry Schein board chairman and CEO Stanley Bergman said: “The acquisition of S.I.N. represents the natural progression of our BOLD+1 Strategy to expand our fast-growing dental specialities businesses, where we have a proven track record of successful acquisitions resulting in profitable growth in addition to our internal growth.”